Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mobiderm made to measure thigh length open toe
21270002960
|
Mobiderm made to measure thigh length open toe | Lymphoedema Garments | Appliances | No data available |
|
Mobiflex 20mg inj vials
100101040BBADAD
|
Mobiflex | Tenoxicam | Musculoskeletal and Joint Diseases | No data available |
|
Mobigel 4% spray
1003020U0BHAAAH
|
Mobigel | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Mobigel Paineze 4% spray
1003020U0BHACAH
|
Mobigel | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Mobile SL catheter female 8Ch-14Ch
21020001345
|
Mobile SL catheter female 8Ch-14Ch | Catheters | Appliances | No data available |
|
Mobile SL catheter male 10Ch-16Ch
21020001344
|
Mobile SL catheter male 10Ch-16Ch | Catheters | Appliances | No data available |
|
Mobile SL catheter male Tiemann tip 12Ch-16Ch
21020001347
|
Mobile SL catheter male Tiemann tip 12Ch-16Ch | Catheters | Appliances | No data available |
|
Mobile SL catheter paediatric 8Ch-10Ch
21020001346
|
Mobile SL catheter paediatric 8Ch-10Ch | Catheters | Appliances | No data available |
|
MobiLoc catheter male 12Ch-14Ch
21020001380
|
MobiLoc catheter male 12Ch-14Ch | Catheters | Appliances | No data available |
|
MobiLoc catheter paediatric 8Ch-10Ch
21020001381
|
MobiLoc catheter paediatric 8Ch-10Ch | Catheters | Appliances | No data available |
|
Moclobemide 150mg/5ml oral suspension
0403020K0AAADAD
|
Moclobemide | Moclobemide | Central Nervous System | No data available |
|
Moclobemide 50mg/5ml oral suspension
0403020K0AAAEAE
|
Moclobemide | Moclobemide | Central Nervous System | No data available |
|
Modafinil 200mg/5ml oral solution
0404000R0AAAFAF
|
Modafinil | Modafinil | Central Nervous System | No data available |
|
Modecate 12.5mg/0.5ml solution for injection ampoules
0402020L0BBAAAA
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 250mg/10ml solution for injection vials
0402020L0BBADAE
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml inj ampoules (Imported (Denmark))
0402020L0BBAHAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml inj ampoules (Imported (Germany))
0402020L0BBAIAC
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 25mg/1ml solution for injection pre-filled syringes
0402020L0BBADAG
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 50mg/2ml solution for injection ampoules
0402020L0BBACAD
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate 50mg/2ml solution for injection pre-filled syringes
0402020L0BBAEAH
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate Concentrate 100mg/1ml inj amp (Imported (Germany))
0402020L0BBAJAF
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Modecate Concentrate 50mg/0.5ml inj ampoules
0402020L0BBAFAB
|
Modecate | Fluphenazine decanoate | Central Nervous System | No data available |
|
Moderex Border Plus dressing 10cm x 10cm
20033000243
|
Moderex Border Plus dressing 10cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Moderex Border Plus dressing 15cm x 15cm
20033000244
|
Moderex Border Plus dressing 15cm x 15cm | Wound Management & Other Dressings | Dressings | No data available |
|
Moderex Border Plus dressing 23.5cm x 25cm sacral
20033000245
|
Moderex Border Plus dressing 23.5cm x 25cm sacral | Wound Management & Other Dressings | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.